Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism  

作　　者：Er-Lei Zhang Zun-Yi Zhang Zhi-Yong Huang 

机构地区：[1]Hepatic Surgery Center,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China

出　　处：《Hepatobiliary Surgery and Nutrition》2023年第1期137-139,共3页肝胆外科与营养（英文）

摘　　要：Hepatocellular carcinoma(HCC)is the second leading cause of cancer-related deaths globally and is widely considered to be a serious threat to human health.In clinical settings,more than 70%of HCCs are unresectable at initial diagnosis and are therefore treated with palliative rather than curative treatment,which severely reduces the overall survival of HCC patients(1).

关 键 词：DIAGNOSIS CARCINOMA CURATIVE 

分 类 号：R735.7[医药卫生—肿瘤]